Skip to main content
Clinical Trials/NCT04310345
NCT04310345
Completed
Not Applicable

Exploring the Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents

Vanderbilt-Ingram Cancer Center1 site in 1 country74 target enrollmentMarch 31, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Advanced Cancer
Sponsor
Vanderbilt-Ingram Cancer Center
Enrollment
74
Locations
1
Primary Endpoint
Pediatric Quality of Life
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study will evaluate the effects of human-animal interaction on reducing anxiety, depression, worry, and pain and enhancing quality of life in children ages 6-17 years old with a life threatening cancer and their parent caregivers.

Detailed Description

Objectives: * To examine the feasibility of human-animal interaction (HAI) sessions for children with a life threatening cancer and a primary caregiver, specifically to: * To identify and document necessary modifications for a safe and feasible intervention * To obtain recruitment estimates and determine potential recruitment barriers * To evaluate elements of implementation fidelity (design, training, delivery/receipt of treatment, enactment) * To verify safety * To determine the preliminary efficacy of human-animal interaction sessions: * On children with a life threatening cancer for the outcomes of qualify of life, anxiety, depression, worry, and pain * On caregivers of children with a life threatening cancer for the outcomes of stress and anxiety Exploratory Objective: - To explore mechanisms (reduced salivary cortisol and urinary norepinephrine levels) associated with 8 weeks of human-animal interaction.

Registry
clinicaltrials.gov
Start Date
March 31, 2021
End Date
June 27, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Maryjo Gilmer

Principal Investigator

Vanderbilt-Ingram Cancer Center

Eligibility Criteria

Inclusion Criteria

  • Children age 6-17 years old that have been diagnosed with advanced cancer as defined by any stage of relapsed, recurrent or refractory cancer
  • Able to understand English or Spanish to complete consents and surveys
  • Parent or Guardian:
  • Parent or guardian as determined by person who brings child to \>50% of their clinic visits
  • Able to understand English or Spanish to complete consents and surveys
  • Exclusion Criteria for both Children and Parent/Guardian:
  • Self-reported fear of or allergies to canines
  • Cognitive impairment as identified by healthcare team or inability to complete consenting process

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Pediatric Quality of Life

Time Frame: Up to 2 months

The Pediatric Quality of Life Inventory (PedsQL) was administered to children and their parents (proxy for child quality of life) at baseline, week 4, and week 8 visits. Weeks 4 and 8 were after interacting with a therapy dog. Baseline surveys collected without seeing a therapy dog. The PedsQL Measurement is a validated scale to assess health-related quality of life in children and adolescents with acute and chronic health conditions. Scores are scaled from 1-100, with higher scores indicative of better quality of life.

Anxiety

Time Frame: Up to 2 months

The state-trait anxiety inventory State sub scale was administered to children (STAI-Child) and their parents (STAI) at baseline, week 4, and week 8. The 20-item STAI-CH is a validated scale for anxiety in children aged 5-17; the 20-item STAI is validated to assess anxiety in adult participants. The State subscale is intended to assess level of anxiety at the time of survey administration. Possible range of scores of the STAI-CH State subscale is 20-60, while the possible range from the STAI state subscale for adults is 20-80. Higher scores are indicative of increased anxiety. Baseline data were obtained without seeing a therapy dog, whereas STAI-CH and STAI surveys were conducted after seeing the therapy dog at weeks 4 and 8.

Study Sites (1)

Loading locations...

Similar Trials